LENZ (LENZ Therapeutics) Ending Cash Position : $41.16 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics Ending Cash Position?

LENZ Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2024 was $41.16 Mil.

LENZ Therapeutics's quarterly Ending Cash Position declined from Mar. 2024 ($200.47 Mil) to Jun. 2024 ($84.15 Mil) and declined from Jun. 2024 ($84.15 Mil) to Sep. 2024 ($41.16 Mil).

LENZ Therapeutics's annual Ending Cash Position increased from Dec. 2021 ($18.31 Mil) to Dec. 2022 ($44.44 Mil) but then declined from Dec. 2022 ($44.44 Mil) to Dec. 2023 ($35.14 Mil).

LENZ Therapeutics Ending Cash Position Historical Data

The historical data trend for LENZ Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics Ending Cash Position Chart

LENZ Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Ending Cash Position

18.31

44.44

35.14

LENZ Therapeutics Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial					42.85	35.14	200.47	84.15	41.16

LENZ Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

LENZ Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	44.441	+	-9.301
	=	35.14

LENZ Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	84.149	+	-42.989
	=	41.16

LENZ Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

LENZ Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

445 Marine View Avenue, STE No. 320, Del Mar, CA, USA, 92014

Website

https://www.lenz-tx.com

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.